- Home
- DYAI vs NYC Comparison
DYAI vs NYC Comparison
Compare DYAI & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- NYC
- Stock Information
- Founded
- DYAI 1979
- NYC 2013
- Country
- DYAI United States
- NYC United States
- Employees
- DYAI N/A
- NYC N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- NYC Real Estate
- Sector
- DYAI Health Care
- NYC Finance
- Exchange
- DYAI Nasdaq
- NYC Nasdaq
- Market Cap
- DYAI 30.2M
- NYC 28.8M
- IPO Year
- DYAI 2004
- NYC N/A
- Fundamental
- Price
- DYAI $0.95
- NYC $10.53
- Analyst Decision
- DYAI Strong Buy
- NYC
- Analyst Count
- DYAI 1
- NYC 0
- Target Price
- DYAI $6.00
- NYC N/A
- AVG Volume (30 Days)
- DYAI 124.7K
- NYC 1.4K
- Earning Date
- DYAI 08-13-2025
- NYC 08-08-2025
- Dividend Yield
- DYAI N/A
- NYC N/A
- EPS Growth
- DYAI N/A
- NYC N/A
- EPS
- DYAI N/A
- NYC N/A
- Revenue
- DYAI $4,135,078.00
- NYC $54,865,000.00
- Revenue This Year
- DYAI $34.23
- NYC $8.40
- Revenue Next Year
- DYAI $19.57
- NYC $1.62
- P/E Ratio
- DYAI N/A
- NYC N/A
- Revenue Growth
- DYAI 129.20
- NYC N/A
- 52 Week Low
- DYAI $0.71
- NYC $7.89
- 52 Week High
- DYAI $2.20
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- DYAI 55.15
- NYC 35.88
- Support Level
- DYAI $0.76
- NYC $10.51
- Resistance Level
- DYAI $0.98
- NYC $11.38
- Average True Range (ATR)
- DYAI 0.07
- NYC 0.59
- MACD
- DYAI 0.02
- NYC -0.16
- Stochastic Oscillator
- DYAI 89.52
- NYC 23.21
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.